Ajanta Pharma Limited (BOM:532331)

Ajanta Pharma Revenue

Ajanta Pharma had revenue of 16.26B INR in the quarter ending June 30, 2026, with 24.82% growth. This brings the company's total for the last twelve months to 57.76B, up 20.19% year-over-year. In the fiscal year ending March 31, 2026, Ajanta Pharma had annual revenue of 54.53B with 17.31% growth.

• Revenue (ttm): 57.76B
• Revenue Growth: +20.19%
• P/S Ratio: 7.48
• Revenue / Employee: 5.54M
• Employees: 10,421
• Market Cap: 432.25B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Emerging Market 20.37B 37.7%
• India 16.54B 30.6%
• United States 15.57B 28.8%
• Africa 1.60B 3.0%

Fiscal year ended Mar 31, 2026 See the full Ajanta Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	54.53B	8.05B	17.31%
Mar 31, 2025	46.48B	4.39B	10.44%
Mar 31, 2024	42.09B	4.66B	12.45%
Mar 31, 2023	37.43B	4.02B	12.02%
Mar 31, 2022	33.41B	4.51B	15.62%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error